Soft Tissue Sarcoma Update, Issue 1, 2017 (Video Program)

Integration of trabectedin and eribulin into the clinical management of leiomyosarcoma and liposarcoma
3:14 minutes.

Classification, incidence and management of sarcomas

Integration of the recently FDA-approved agents trabectedin and eribulin into the treatment algorithms for metastatic liposarcoma and leiomyosarcoma

Recent FDA approval of olaratumab in combination with doxorubicin and integration into the treatment algorithm for advanced STS

Role of tyrosine kinase inhibitors and immune checkpoint inhibitors in STS